Results 221 to 230 of about 1,337,614 (304)
VETERANS ADMINISTRATION SURGICAL ADJUVANT LUNG CANCER CHEMOTHERAPY STUDY: PRESENT STATUS
Felix A. Hughes, George A. Higgins
openalex +1 more source
A galactose‐modified supramolecular near‐infrared (NIR) glycoprobe, TCF‐FBN@Gal‐BSA, enables targeted delivery to the liver through the asialoglycoprotein receptor (ASGPR) and facilitates liver‐targeting fluorescence visualization of lipid droplets (LDs) in metabolic dysfunction‐associated steatotic liver disease (MASLD) mice.
Han‐Min Wang+12 more
wiley +1 more source
Lung cancer: Animal model of lung cancer, molecular carcinogenesis of lung cancer, and antitumor effect of <i>Ocimum sanctum</i> against lung cancer. [PDF]
Kustiati U+3 more
europepmc +1 more source
This review highlights recent advances in engineering artificial antigen‐presenting cells (aAPCs) as alternatives to dendritic cells for T cell expansion. Key design principles inspired by the immunological synapse are discussed, with emphasis on strategies for polyclonal and antigen‐specific T cell expansion.
Nguyen Thi Nguyen, Yu Seok Youn
wiley +1 more source
Pulmonary cytology: Pearls and pitfalls of non-neoplastic mimics of lung cancer. [PDF]
Robledano R+3 more
europepmc +1 more source
Flow‐Induced Vascular Remodeling on‐Chip: Implications for Anti‐VEGF Therapy
Flow‐induced vascular remodeling plays a critical role in network stabilization and function. Using a vasculature‐on‐chip system, this study reveals how physiological VEGF levels and flow affect vascular remodeling and provides insights into tumor vessel normalization.
Fatemeh Mirzapour‐Shafiyi+6 more
wiley +1 more source
Emerging Targets in Non-Small Cell Lung Cancer. [PDF]
Wang J, Biglow L, Baumgart M.
europepmc +1 more source
Plasma‐Treated Hydrogel for Combined RONS and Chemotherapy Delivery: A Proof‐of‐Concept In Ovo
This study explores plasma‐treated hydrogels (PTH) as a new way to deliver both reactive oxygen and nitrogen species and chemotherapy (Doxorubicin) directly to tumors. In ovo tests show effects after a single dose, especially in osteosarcoma tumors. Tumor weight decrease, and a resistance‐related protein is reduced.
Milica Živanić+9 more
wiley +1 more source
Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms. [PDF]
Yu X+5 more
europepmc +1 more source
The Present Position Relating to Cancer of the Lung : Symposium by the Thoracic Society
Ginny Mason
openalex +1 more source